about
Temporal profile of vascular changes induced by systemic nitroglycerin in the meningeal and cortical districts.Effects of anandamide in migraine: data from an animal model.Evaluation of ADMA-DDAH-NOS axis in specific brain areas following nitroglycerin administration: study in an animal model of migraine.Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.Andrographis Paniculata shows anti-nociceptive effects in an animal model of sensory hypersensitivity associated with migraine.Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal modelThe endocannabinoid system and migraine.Transdermal hormonal therapy in perimenstrual migraine: why, when and how?Effects of peripheral FAAH blockade on NTG-induced hyperalgesia--evaluation of URB937 in an animal model of migraine.Neuroprotection by the PARP inhibitor PJ34 modulates cerebral and circulating RAGE levels in rats exposed to focal brain ischemia.Selective stimulation of striatal dopamine receptors of the D1- or D2-class causes opposite changes of fos expression in the rat cerebral cortex.Functional and neurochemical changes of the gastrointestinal tract in a rodent model of Parkinson's disease.Alterations of the endocannabinoid system in an animal model of migraine: evaluation in cerebral areas of rat.Effect of sex and estrogens on neuronal activation in an animal model of migraine.Effects of the intrastriatal administration of selective dopaminergic agonists on Fos expression in the rat brain.Effects of CGRP receptor antagonism in nitroglycerin-induced hyperalgesia.Modulation of RAGE isoforms expression in the brain and plasma of rats exposed to transient focal cerebral ischemia.Role of central dopaminergic circuitry in pain processing and nitroglycerin-induced hyperalgesia.Effects of acute and chronic restraint stress on nitroglycerin-induced hyperalgesia in rats.Comparative analysis of the neuronal activation and cardiovascular effects of nitroglycerin, sodium nitroprusside and L-arginine.Role of calcitonin gene-related peptide and substance P in different models of pain.Prostaglandins, glutamate and nitric oxide synthase mediate nitroglycerin-induced hyperalgesia in the formalin test.Selective lesion of the substantia nigra pars reticulata reduces the cortical Fos expression induced by stimulation of striatal D1-like receptors, in the rat.Behavioral responses and Fos activation following painful stimuli in a rodent model of Parkinson's disease.Endothelial nitric oxide synthase inhibition triggers inflammatory responses in the brain of male rats exposed to ischemia-reperfusion injury.Unilateral lesion of the subthalamic nucleus enhances cortical fos expression associated with focally evoked seizures in the rat.Activation of the transcription factor NF-kappaB in the nucleus trigeminalis caudalis in an animal model of migraine.Neuroprotective Effect of Nitroglycerin in a Rodent Model of Ischemic Stroke: Evaluation of Bcl‐2 ExpressionNitroglycerin induces hyperalgesia in rats--a time-course studyNitroglycerin enhances cGMP expression in specific neuronal and cerebrovascular structures of the rat brainA role for brain cyclooxygenase-2 and prostaglandin-E2 in migraine: effects of nitroglycerinIkappaB-alpha expression following transient focal cerebral ischemia is modulated by nitric oxideChronic and intermittent administration of systemic nitroglycerin in the rat induces an increase in the gene expression of CGRP in central areas: potential contribution to pain processingFAAH inhibition as a preventive treatment for migraine: A pre-clinical study
P50
Q33652269-E27DCBC1-B515-4C6F-A742-FBB08C6F8188Q33823790-DAF2209A-005D-4FD2-9C72-6AA87452502EQ35952529-B5EDE511-7273-4EFB-9570-248D58E2655FQ35975405-376FC3AA-5F0B-4032-9E46-B22ACA6FD42DQ36762541-3A47F293-7C3A-4872-B3F7-0552EBA90030Q37716463-A623165F-E2DA-4C3C-A9B5-941BEF902404Q37721545-6812083C-29FE-4397-B526-5B4D6C19A9D9Q38038990-533B4F73-58BE-4703-8434-F7CC51C354E7Q41547699-5C086E57-6A22-4D2F-BDA6-1426D563B3F7Q41758996-1C9F8CC9-D110-4471-A518-B6E28BD67C0DQ42437472-7285A1EE-811D-48DB-A3F5-300E045F20A7Q43260033-BA20AA69-0B36-4462-B62D-62CB387CF7B3Q43685286-694D79DB-8157-49E3-AD0B-B6F610F0FA72Q44191419-606EAB27-8895-4DBA-AD82-49912CF13F64Q44291640-2C6BA162-BD27-44BB-8035-D7488677246AQ46010921-D31FC987-46CC-4784-9C94-193105B6FE3CQ46216878-8FEE632E-A951-4198-AE77-FDCF44A3B408Q46399203-D00FADC5-1BCA-4DCD-AE86-FEA5FA0FE571Q46528496-8661D24E-2834-42A0-8E76-598CE38B4240Q46591594-1500A123-2831-4327-AB70-D6C1048D2988Q46806356-8DC95A27-12E5-4414-9EC7-FFBC8AEFD298Q46968287-AA3DE0F2-2E0F-4061-AEF3-05FB21652A12Q46975293-F3EA0CDE-D9B7-47AB-BD9B-3267DCEF333EQ46990142-193B10CE-16D5-4198-842D-91B71AE2A9BCQ48284118-2AABA8C1-8A7A-4EA4-83CA-F3F43BF50B2FQ48494137-B5D57C8C-C1BA-4F73-A10E-BE45E40E9966Q48868739-7C6D9405-5B32-4A4D-925E-665857EB498AQ61896999-17AD104A-1C87-41E7-8C98-B096679380D3Q73087123-425A49EB-2F02-47D1-A402-746E4F1F4ADFQ79809439-BB7868F3-A524-4C90-9DDE-048DB4EBBF14Q80748094-04023267-EC75-442C-B177-959F796AB71FQ82691670-9CA17118-D99F-4C5E-AB18-DDB565585A04Q90019392-B7DCD881-801B-4204-8F10-2B207900C356Q90822657-E528BB27-9030-48AE-817B-EDA832916B40
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rosaria Greco
@ast
Rosaria Greco
@en
Rosaria Greco
@es
Rosaria Greco
@nl
Rosaria Greco
@sl
type
label
Rosaria Greco
@ast
Rosaria Greco
@en
Rosaria Greco
@es
Rosaria Greco
@nl
Rosaria Greco
@sl
prefLabel
Rosaria Greco
@ast
Rosaria Greco
@en
Rosaria Greco
@es
Rosaria Greco
@nl
Rosaria Greco
@sl
P1053
K-8828-2016
P106
P1153
7103137154
P21
P31
P3829
P496
0000-0001-6577-0629